Tao Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tao Yuan has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Hong Ma
Department of Spine Surgery Second Xiangya Hospital of Central South University Changsha China
3 shared publicationsYuliang Dai
Department of Spine Surgery Second Xiangya Hospital of Central South University Changsha China
3 shared publicationsZhiming Tu
Department of Spine Surgery Second Xiangya Hospital of Central South University Changsha China
3 shared publicationsBing Wang
2 shared publications- Bing Wang
Department of Spine Surgery, The Second Xiangya Hospital of Central South University, Changsha 410011, China
2 shared publications - Liang Chen
School of Nursing, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
2 shared publications
Latest Publications
- Open Access
- 27 September 2026
- Published by Wiley in Advanced Science
Liquid‐Responsive Shape‐Memory Nanofiber‐Reinforced Scaffolds for Cartilage Repair
Bioengineered scaffolds hold promise for articular cartilage repair but are often limited by poor defect conformity, insufficient availability of endogenous reparative cells, and inadequate chondrogenic stimulation. Here, we developed a liquid‐responsive shape‐memory, core–shell nanofiber‐reinforced, directionally porous scaffold (QCG‐2%F/KGN) for endogenous cartilage regeneration. KGN‐loaded SF/PCL–PVA core–shell nanofibers were fabricated by coaxial electrospinning, fragmented, incorporated into a quaternized chitosan/gelatin matrix, and assembled by directional freeze‐casting. The aligned microchannels provided a structurally permissive route for cell infiltration and distribution, while the nanofiber network enhanced pore‐wall roughness, structural stability, water retention, and hydration‐triggered shape recovery. The core–shell fibers also enabled sustained KGN release over 30‐day period. In vitro, QCG‐2%F/KGN maintained high cell viability and promoted BMSC migratory activity, spreading, chondrogenic differentiation, and cartilage‐matrix deposition. In a rat full‐thickness cartilage‐defect model, the scaffold conformally filled the defect and enhanced hyaline cartilage like regeneration, accompanied by increased SOX9, COL2A1, and ACAN and decreased COL1A1 and MMP13. Transcriptomic analysis further indicated enrichment of cartilage‐anabolic programs and attenuation of inflammatory signaling. These findings support a sequential regenerative strategy integrating shape‐adaptive implantation, a microarchitecture favorable for endogenous cell infiltration, and sustained chondrogenic induction.
- 27 September 2026
- Published by Wiley in Advanced Science
Open AccessLiquid‐Responsive Shape‐Memory Nanofiber‐Reinforced Scaffolds for Cartilage Repair
Bioengineered scaffolds hold promise for articular cartilage repair but are often limited by poor defect conformity, insufficient availability of endogenous reparative cells, and inadequate chondrogenic stimulation. Here, we developed a liquid‐responsive shape‐memory, core–shell nanofiber‐reinforced, directionally porous scaffold (QCG‐2%F/KGN) for endogenous cartilage regeneration. KGN‐loaded SF/PCL–PVA core–shell nanofibers were fabricated by coaxial electrospinning, fragmented, incorporated into a quaternized chitosan/gelatin matrix, and assembled by directional freeze‐casting. The aligned microchannels provided a structurally permissive route for cell infiltration and distribution, while the nanofiber network enhanced pore‐wall roughness, structural stability, water retention, and hydration‐triggered shape recovery. The core–shell fibers also enabled sustained KGN release over 30‐day period. In vitro, QCG‐2%F/KGN maintained high cell viability and promoted BMSC migratory activity, spreading, chondrogenic differentiation, and cartilage‐matrix deposition. In a rat full‐thickness cartilage‐defect model, the scaffold conformally filled the defect and enhanced hyaline cartilage like regeneration, accompanied by increased SOX9, COL2A1, and ACAN and decreased COL1A1 and MMP13. Transcriptomic analysis further indicated enrichment of cartilage‐anabolic programs and attenuation of inflammatory signaling. These findings support a sequential regenerative strategy integrating shape‐adaptive implantation, a microarchitecture favorable for endogenous cell infiltration, and sustained chondrogenic induction.
- Open Access
- 29 June 2026
- Published by Elsevier in Materials Today Bio
- Vol. 39
Smart functionalized cartilage repair microspheres: Concepts and applications
- 29 June 2026
- Published by Elsevier in Materials Today Bio
- Vol. 39
Open AccessSmart functionalized cartilage repair microspheres: Concepts and applications
Intra‐Articular Injectable Hydrogel Microsphere‐Based Drug Delivery System for Osteoarthritis Treatment
The prevalence of osteoarthritis (OA), a chronic degenerative joint disease characterized by heterogeneity, is increasing annually owing to factors such as population aging and obesity, which present growing health and economic burdens. Traditional therapies can only slow the progression of OA. The substantial adverse effects of the classical route of administration and complications associated with surgery have highlighted the urgent need for novel therapeutic approaches. As an innovative breakthrough in the field of OA treatment, hydrogel microsphere technology can be used to build a biomimetic microenvironment for cartilage regeneration and establish intelligent drug release owing to its precisely regulated physicochemical properties and excellent biocompatibility. This review first examines the changes in the joint microenvironment and injection barriers caused by OA. The requisite properties of hydrogel microspheres for OA treatment are summarized, and their preparation methods, structural characteristics, and modification strategies are explored. Furthermore, we discuss their application as delivery systems and address the current challenges and future perspectives to enhance their therapeutic efficacy.
Intra‐Articular Injectable Hydrogel Microsphere‐Based Drug Delivery System for Osteoarthritis Treatment
The prevalence of osteoarthritis (OA), a chronic degenerative joint disease characterized by heterogeneity, is increasing annually owing to factors such as population aging and obesity, which present growing health and economic burdens. Traditional therapies can only slow the progression of OA. The substantial adverse effects of the classical route of administration and complications associated with surgery have highlighted the urgent need for novel therapeutic approaches. As an innovative breakthrough in the field of OA treatment, hydrogel microsphere technology can be used to build a biomimetic microenvironment for cartilage regeneration and establish intelligent drug release owing to its precisely regulated physicochemical properties and excellent biocompatibility. This review first examines the changes in the joint microenvironment and injection barriers caused by OA. The requisite properties of hydrogel microspheres for OA treatment are summarized, and their preparation methods, structural characteristics, and modification strategies are explored. Furthermore, we discuss their application as delivery systems and address the current challenges and future perspectives to enhance their therapeutic efficacy.
- Open Access
- 18 November 2025
- Published by Elsevier in Materials & Design
- Vol. 260
Engineering healthy aging: A review of biomedical platforms for mechanistic intervention in geriatric decline
- 18 November 2025
- Published by Elsevier in Materials & Design
- Vol. 260
Open AccessEngineering healthy aging: A review of biomedical platforms for mechanistic intervention in geriatric decline
- Open Access
- 23 June 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 102014
Beyond natural silk: Bioengineered silk fibroin for bone regeneration
- 23 June 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 102014
Open AccessBeyond natural silk: Bioengineered silk fibroin for bone regeneration
- Open Access
- 1 June 2025
- Published by AIP Publishing in APL Materials
- Vol. 13 (6)
Spinal cord injury repair: Mechanisms, applications, and prospects of hydrogel therapies
Spinal cord injury (SCI) is a severe condition of the central nervous system that leads to significant functional impairments and imposes heavy socioeconomic burdens. Despite recent advancements, traditional treatments remain limited in terms of efficacy and are often associated with complications. Emerging therapies, including stem cell technologies and biomaterials, have shown promise in addressing the challenges associated with SCI recovery. Among these, hydrogels have gained considerable attention, owing to their excellent biocompatibility and adaptability, in addition to their ability to provide an optimal repair microenvironment. Importantly, hydrogels can serve as scaffolds for cell growth, drug delivery systems, or tools for modulating inflammatory responses and oxidative stress. This review comprehensively examines hydrogel-based therapies for the treatment of SCI, focusing on the mechanisms underlying secondary injury. The preparation of hydrogels and their application in promoting nerve regeneration, reducing scar formation, and mitigating oxidative damage are also presented. Furthermore, this review highlights the potential of hydrogels to facilitate macrophage polarization, increase the viability of stem cells, and enhance drug delivery precision. Despite these advancements, challenges remain, including optimization of material properties and achievement of targeted interventions. Future research should focus on developing smart hydrogels that adapt to the SCI microenvironment, investigate the integration of gene and physical therapies, and elucidate the molecular pathways involved in hydrogel-mediated regeneration. With continued innovation, hydrogels hold transformative potential in SCI treatment, being promising for improved functional recovery and patient outcomes.
- 1 June 2025
- Published by AIP Publishing in APL Materials
- Vol. 13 (6)
Open AccessSpinal cord injury repair: Mechanisms, applications, and prospects of hydrogel therapies
Spinal cord injury (SCI) is a severe condition of the central nervous system that leads to significant functional impairments and imposes heavy socioeconomic burdens. Despite recent advancements, traditional treatments remain limited in terms of efficacy and are often associated with complications. Emerging therapies, including stem cell technologies and biomaterials, have shown promise in addressing the challenges associated with SCI recovery. Among these, hydrogels have gained considerable attention, owing to their excellent biocompatibility and adaptability, in addition to their ability to provide an optimal repair microenvironment. Importantly, hydrogels can serve as scaffolds for cell growth, drug delivery systems, or tools for modulating inflammatory responses and oxidative stress. This review comprehensively examines hydrogel-based therapies for the treatment of SCI, focusing on the mechanisms underlying secondary injury. The preparation of hydrogels and their application in promoting nerve regeneration, reducing scar formation, and mitigating oxidative damage are also presented. Furthermore, this review highlights the potential of hydrogels to facilitate macrophage polarization, increase the viability of stem cells, and enhance drug delivery precision. Despite these advancements, challenges remain, including optimization of material properties and achievement of targeted interventions. Future research should focus on developing smart hydrogels that adapt to the SCI microenvironment, investigate the integration of gene and physical therapies, and elucidate the molecular pathways involved in hydrogel-mediated regeneration. With continued innovation, hydrogels hold transformative potential in SCI treatment, being promising for improved functional recovery and patient outcomes.
- Top Cited Papers
- 13 September 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (44) , e2411628
Biomimetic Multichannel Silk Nerve Conduits With Multicellular Spatiotemporal Distributions for Spinal Cord Injury Repair
Bioengineered nerve conduits have shown great promise for spinal cord injury (SCI) repair, while their practical values are limited by poor regenerative efficacy and lack of multi‐level structural design. Here, inspired by the ingenious anatomy of natural spinal cords, a biomimetic multichannel silk nerve conduit (namely BNC@MSCs/SCs) with multicellular spatiotemporal distributions for effective SCI repair is presented. The biomimetic silk nerve conduit (BNC) with hierarchical channels and aligned pore structures is prepared via a modified directional freeze‐casting strategy. Such hierarchical structures provide appropriate space for the mesenchymal stem cells (MSCs) and Schwann cells (SCs) settled in specific channels, which contributes to the generation of BNC@MSCs/SCs resembling the cellular spatiotemporal distributions of natural spinal cords. The in vitro results reveal the facilitated SC migration and MSC differentiation in such BNC@MSCs/SCs multicellular system, which further promotes the tube formation and cell migration of endothelial cells as well as M2 polarization of macrophages. Moreover, BNC@MSCs/SCs can effectively promote the tissue repair and function recovery in SCI rats by attenuating glial scar formation while promoting neuron regeneration and myelin sheath reconstruction. Thus, it is believed that the biomimetic multichannel silk nerve conduits with multicellular spatiotemporal distributions are valuable for SCI repair and other neural tissue regeneration.
- 13 September 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (44) , e2411628
Top Cited PapersBiomimetic Multichannel Silk Nerve Conduits With Multicellular Spatiotemporal Distributions for Spinal Cord Injury Repair
Bioengineered nerve conduits have shown great promise for spinal cord injury (SCI) repair, while their practical values are limited by poor regenerative efficacy and lack of multi‐level structural design. Here, inspired by the ingenious anatomy of natural spinal cords, a biomimetic multichannel silk nerve conduit (namely BNC@MSCs/SCs) with multicellular spatiotemporal distributions for effective SCI repair is presented. The biomimetic silk nerve conduit (BNC) with hierarchical channels and aligned pore structures is prepared via a modified directional freeze‐casting strategy. Such hierarchical structures provide appropriate space for the mesenchymal stem cells (MSCs) and Schwann cells (SCs) settled in specific channels, which contributes to the generation of BNC@MSCs/SCs resembling the cellular spatiotemporal distributions of natural spinal cords. The in vitro results reveal the facilitated SC migration and MSC differentiation in such BNC@MSCs/SCs multicellular system, which further promotes the tube formation and cell migration of endothelial cells as well as M2 polarization of macrophages. Moreover, BNC@MSCs/SCs can effectively promote the tissue repair and function recovery in SCI rats by attenuating glial scar formation while promoting neuron regeneration and myelin sheath reconstruction. Thus, it is believed that the biomimetic multichannel silk nerve conduits with multicellular spatiotemporal distributions are valuable for SCI repair and other neural tissue regeneration.